Docality.com Logo
 
Dr. Roland  Hart  Md image

Dr. Roland Hart Md

2545 W Hammer Ln
Stockton CA 95209
209 577-7050
Medical School: Meharry Medical College School Of Medicine - 1968
Accepts Medicare: Yes
Participates In eRX: Yes
Participates In PQRS: Yes
Participates In EHR: Yes
License #: C34191
NPI: 1821047705
Taxonomy Codes:
207N00000X

Request Appointment Information

Awards & Recognitions

About Us

Practice Philosophy

Conditions

Dr. Roland Hart is associated with these group practices

Procedure Pricing

HCPCS Code Description Average Price Average Price
Allowed By Medicare
HCPCS Code:11606 Description:Exc tr-ext mal+marg > 4 cm Average Price:$1,357.00 Average Price Allowed
By Medicare:
$436.44
HCPCS Code:11644 Description:Exc f/e/e/n/l mal+mrg 3.1-4 Average Price:$1,288.00 Average Price Allowed
By Medicare:
$391.11
HCPCS Code:11643 Description:Exc f/e/e/n/l mal+mrg 2.1-3 Average Price:$1,040.00 Average Price Allowed
By Medicare:
$315.04
HCPCS Code:11604 Description:Exc tr-ext mal+marg 3.1-4 cm Average Price:$977.00 Average Price Allowed
By Medicare:
$293.56
HCPCS Code:11642 Description:Exc f/e/e/n/l mal+mrg 1.1-2 Average Price:$887.00 Average Price Allowed
By Medicare:
$246.85
HCPCS Code:11603 Description:Exc tr-ext mal+marg 2.1-3 cm Average Price:$886.00 Average Price Allowed
By Medicare:
$257.21
HCPCS Code:11404 Description:Exc tr-ext b9+marg 3.1-4 cm Average Price:$688.00 Average Price Allowed
By Medicare:
$184.90
HCPCS Code:11403 Description:Exc tr-ext b9+marg 2.1-3 cm Average Price:$606.00 Average Price Allowed
By Medicare:
$186.59
HCPCS Code:17004 Description:Destroy premal lesions 15/> Average Price:$586.00 Average Price Allowed
By Medicare:
$177.72
HCPCS Code:17111 Description:Destruct lesion 15 or more Average Price:$412.00 Average Price Allowed
By Medicare:
$138.34
HCPCS Code:11100 Description:Biopsy skin lesion Average Price:$334.00 Average Price Allowed
By Medicare:
$98.65
HCPCS Code:11301 Description:Shave skin lesion Average Price:$304.00 Average Price Allowed
By Medicare:
$70.85
HCPCS Code:17110 Description:Destruct b9 lesion 1-14 Average Price:$340.00 Average Price Allowed
By Medicare:
$117.02
HCPCS Code:17000 Description:Destruct premalg lesion Average Price:$257.00 Average Price Allowed
By Medicare:
$74.74
HCPCS Code:11900 Description:Injection into skin lesions Average Price:$183.00 Average Price Allowed
By Medicare:
$54.04
HCPCS Code:99202 Description:Office/outpatient visit new Average Price:$197.00 Average Price Allowed
By Medicare:
$75.45
HCPCS Code:99213 Description:Office/outpatient visit est Average Price:$190.00 Average Price Allowed
By Medicare:
$73.15
HCPCS Code:11101 Description:Biopsy skin add-on Average Price:$109.00 Average Price Allowed
By Medicare:
$33.69
HCPCS Code:99212 Description:Office/outpatient visit est Average Price:$119.00 Average Price Allowed
By Medicare:
$44.43
HCPCS Code:96372 Description:Ther/proph/diag inj sc/im Average Price:$72.00 Average Price Allowed
By Medicare:
$25.68
HCPCS Code:96900 Description:Ultraviolet light therapy Average Price:$68.00 Average Price Allowed
By Medicare:
$23.08
HCPCS Code:17003 Description:Destruct premalg les 2-14 Average Price:$27.00 Average Price Allowed
By Medicare:
$7.43
HCPCS Code:J3301 Description:Triamcinolone acet inj NOS Average Price:$4.00 Average Price Allowed
By Medicare:
$1.69

HCPCS Code Definitions

11644
Excision, malignant lesion including margins, face, ears, eyelids, nose, lips; excised diameter 3.1 to 4.0 cm
11900
Injection, intralesional; up to and including 7 lesions
99212
Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: A problem focused history; A problem focused examination; Straightforward medical decision making. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are self limited or minor. Typically, 10 minutes are spent face-to-face with the patient and/or family.
17110
Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions
17004
Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses), 15 or more lesions
17003
Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); second through 14 lesions, each (List separately in addition to code for first lesion)
99202
Office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: An expanded problem focused history; An expanded problem focused examination; Straightforward medical decision making. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of low to moderate severity. Typically, 20 minutes are spent face-to-face with the patient and/or family.
11642
Excision, malignant lesion including margins, face, ears, eyelids, nose, lips; excised diameter 1.1 to 2.0 cm
11643
Excision, malignant lesion including margins, face, ears, eyelids, nose, lips; excised diameter 2.1 to 3.0 cm
96900
Actinotherapy (ultraviolet light)
96372
Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular
17111
Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; 15 or more lesions
J3301
Injection, triamcinolone acetonide, not otherwise specified, 10 mg
99213
Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: An expanded problem focused history; An expanded problem focused examination; Medical decision making of low complexity. Counseling and coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of low to moderate severity. Typically, 15 minutes are spent face-to-face with the patient and/or family.
17000
Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion
11604
Excision, malignant lesion including margins, trunk, arms, or legs; excised diameter 3.1 to 4.0 cm
11606
Excision, malignant lesion including margins, trunk, arms, or legs; excised diameter over 4.0 cm
11603
Excision, malignant lesion including margins, trunk, arms, or legs; excised diameter 2.1 to 3.0 cm
11100
Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; single lesion
11101
Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; each separate/additional lesion (List separately in addition to code for primary procedure)
11301
Shaving of epidermal or dermal lesion, single lesion, trunk, arms or legs; lesion diameter 0.6 to 1.0 cm
11403
Excision, benign lesion including margins, except skin tag (unless listed elsewhere), trunk, arms or legs; excised diameter 2.1 to 3.0 cm
11404
Excision, benign lesion including margins, except skin tag (unless listed elsewhere), trunk, arms or legs; excised diameter 3.1 to 4.0 cm

Medical Malpractice Cases

None Found

Medical Board Sanctions

None Found

Referrals

NPI
Doctor Name
Specialty
Count
1356377071
Hematology/Oncology
1,261
1154369130
Cardiovascular Disease (Cardiology)
1,125
1801884929
Nephrology
1,114
1083679930
Internal Medicine
1,113
1992761357
Internal Medicine
988
1104931260
Family Practice
932
1538280292
Dermatology
842
1508822768
Internal Medicine
780
1679590319
Diagnostic Radiology
754
1154387256
Family Practice
571
*These referrals represent the top 10 that Dr. Hart has made to other doctors

Publications

Constraints on the pMSSM, AMSB model and on other models from the search for long-lived charged particles in proton-proton collisions at [Formula: see text]. - The European physical journal. C, Particles and fields
Stringent limits are set on the long-lived lepton-like sector of the phenomenological minimal supersymmetric standard model (pMSSM) and the anomaly-mediated supersymmetry breaking (AMSB) model. The limits are derived from the results presented in a recent search for long-lived charged particles in proton-proton collisions, based on data collected by the CMS detector at a centre-of-mass energy of 8 TeV at the Large Hadron Collider. In the pMSSM parameter sub-space considered, 95.9 % of the points predicting charginos with a lifetime of at least 10 ns are excluded. These constraints on the pMSSM are the first obtained at the LHC. Charginos with a lifetime greater than 100 ns and masses up to about 800 GeV in the AMSB model are also excluded. The method described can also be used to set constraints on other models.
Distributions of topological observables in inclusive three- and four-jet events in pp collisions at [Formula: see text][Formula: see text]. - The European physical journal. C, Particles and fields
This paper presents distributions of topological observables in inclusive three- and four-jet events produced in pp collisions at a centre-of-mass energy of 7[Formula: see text] with a data sample collected by the CMS experiment corresponding to a luminosity of 5.1[Formula: see text]. The distributions are corrected for detector effects, and compared with several event generators based on two- and multi-parton matrix elements at leading order. Among the considered calculations, MadGraph interfaced with pythia6 displays the overall best agreement with data.
Evidence for Collective Multiparticle Correlations in p-Pb Collisions. - Physical review letters
The second-order azimuthal anisotropy Fourier harmonics, v_{2}, are obtained in p-Pb and PbPb collisions over a wide pseudorapidity (η) range based on correlations among six or more charged particles. The p-Pb data, corresponding to an integrated luminosity of 35  nb^{-1}, were collected during the 2013 LHC p-Pb run at a nucleon-nucleon center-of-mass energy of 5.02  TeV by the CMS experiment. A sample of semiperipheral PbPb collision data at sqrt[s_{NN}]=2.76  TeV, corresponding to an integrated luminosity of 2.5  μb^{-1} and covering a similar range of particle multiplicities as the p-Pb data, is also analyzed for comparison. The six- and eight-particle cumulant and the Lee-Yang zeros methods are used to extract the v_{2} coefficients, extending previous studies of two- and four-particle correlations. For both the p-Pb and PbPb systems, the v_{2} values obtained with correlations among more than four particles are consistent with previously published four-particle results. These data support the interpretation of a collective origin for the previously observed long-range (large Δη) correlations in both systems. The ratios of v_{2} values corresponding to correlations including different numbers of particles are compared to theoretical predictions that assume a hydrodynamic behavior of a p-Pb system dominated by fluctuations in the positions of participant nucleons. These results provide new insights into the multiparticle dynamics of collision systems with a very small overlapping region.
Constraints on parton distribution functions and extraction of the strong coupling constant from the inclusive jet cross section in pp collisions at [Formula: see text][Formula: see text]. - The European physical journal. C, Particles and fields
The inclusive jet cross section for proton-proton collisions at a centre-of-mass energy of 7[Formula: see text] was measured by the CMS Collaboration at the LHC with data corresponding to an integrated luminosity of 5.0[Formula: see text]. The measurement covers a phase space up to 2[Formula: see text] in jet transverse momentum and 2.5 in absolute jet rapidity. The statistical precision of these data leads to stringent constraints on the parton distribution functions of the proton. The data provide important input for the gluon density at high fractions of the proton momentum and for the strong coupling constant at large energy scales. Using predictions from perturbative quantum chromodynamics at next-to-leading order, complemented with electroweak corrections, the constraining power of these data is investigated and the strong coupling constant at the Z boson mass [Formula: see text] is determined to be [Formula: see text], which is in agreement with the world average.
Search for a standard model Higgs boson produced in association with a top-quark pair and decaying to bottom quarks using a matrix element method. - The European physical journal. C, Particles and fields
A search for a standard model Higgs boson produced in association with a top-quark pair and decaying to bottom quarks is presented. Events with hadronic jets and one or two oppositely charged leptons are selected from a data sample corresponding to an integrated luminosity of 19.5[Formula: see text] collected by the CMS experiment at the LHC in [Formula: see text] collisions at a centre-of-mass energy of 8[Formula: see text]. In order to separate the signal from the larger [Formula: see text]  + jets background, this analysis uses a matrix element method that assigns a probability density value to each reconstructed event under signal or background hypotheses. The ratio between the two values is used in a maximum likelihood fit to extract the signal yield. The results are presented in terms of the measured signal strength modifier, [Formula: see text], relative to the standard model prediction for a Higgs boson mass of 125[Formula: see text]. The observed (expected) exclusion limit at a 95 % confidence level is [Formula: see text] (3.3), corresponding to a best fit value [Formula: see text].
Nuclear effects on the transverse momentum spectra of charged particles in pPb collisions at [Formula: see text][Formula: see text]. - The European physical journal. C, Particles and fields
Transverse momentum spectra of charged particles are measured by the CMS experiment at the CERN LHC in pPb collisions at [Formula: see text][Formula: see text], in the range [Formula: see text][Formula: see text] and pseudorapidity [Formula: see text] in the proton-nucleon center-of-mass frame. For [Formula: see text][Formula: see text], the charged-particle production is asymmetric about [Formula: see text], with smaller yield observed in the direction of the proton beam, qualitatively consistent with expectations from shadowing in nuclear parton distribution functions (nPDF). A pp reference spectrum at [Formula: see text][Formula: see text] is obtained by interpolation from previous measurements at higher and lower center-of-mass energies. The [Formula: see text] distribution measured in pPb collisions shows an enhancement of charged particles with [Formula: see text][Formula: see text] compared to expectations from the pp reference. The enhancement is larger than predicted by perturbative quantum chromodynamics calculations that include antishadowing modifications of nPDFs.
Measurements of differential and double-differential Drell-Yan cross sections in proton-proton collisions at [Formula: see text][Formula: see text]. - The European physical journal. C, Particles and fields
Measurements of the differential and double-differential Drell-Yan cross sections in the dielectron and dimuon channels are presented. They are based on proton-proton collision data at [Formula: see text] recorded with the CMS detector at the LHC and corresponding to an integrated luminosity of 19.7[Formula: see text]. The measured inclusive cross section in the [Formula: see text] peak region (60-120[Formula: see text]), obtained from the combination of the dielectron and dimuon channels, is [Formula: see text], where the statistical uncertainty is negligible. The differential cross section [Formula: see text] in the dilepton mass range 15-2000[Formula: see text] is measured and corrected to the full phase space. The double-differential cross section [Formula: see text] is also measured over the mass range 20 to 1500[Formula: see text] and absolute dilepton rapidity from 0 to 2.4. In addition, the ratios of the normalized differential cross sections measured at [Formula: see text] and 8[Formula: see text] are presented. These measurements are compared to the predictions of perturbative QCD at next-to-leading and next-to-next-to-leading (NNLO) orders using various sets of parton distribution functions (PDFs). The results agree with the NNLO theoretical predictions computed with fewz 3.1 using the CT10 NNLO and NNPDF2.1 NNLO PDFs. The measured double-differential cross section and ratio of normalized differential cross sections are sufficiently precise to constrain the proton PDFs.
Combined Measurement of the Higgs Boson Mass in pp Collisions at sqrt[s]=7 and 8 TeV with the ATLAS and CMS Experiments. - Physical review letters
A measurement of the Higgs boson mass is presented based on the combined data samples of the ATLAS and CMS experiments at the CERN LHC in the H→γγ and H→ZZ→4ℓ decay channels. The results are obtained from a simultaneous fit to the reconstructed invariant mass peaks in the two channels and for the two experiments. The measured masses from the individual channels and the two experiments are found to be consistent among themselves. The combined measured mass of the Higgs boson is m_{H}=125.09±0.21 (stat)±0.11 (syst)  GeV.
Measurement of J/ψ and ψ(2S) Prompt Double-Differential Cross Sections in pp Collisions at sqrt[s]=7  TeV. - Physical review letters
The double-differential cross sections of promptly produced J/ψ and ψ(2S) mesons are measured in pp collisions at sqrt[s]=7  TeV, as a function of transverse momentum p_{T} and absolute rapidity |y|. The analysis uses J/ψ and ψ(2S) dimuon samples collected by the CMS experiment, corresponding to integrated luminosities of 4.55 and 4.90  fb^{-1}, respectively. The results are based on a two-dimensional analysis of the dimuon invariant mass and decay length, and extend to p_{T}=120 and 100 GeV for the J/ψ and ψ(2S), respectively, when integrated over the interval |y|<1.2. The ratio of the ψ(2S) to J/ψ cross sections is also reported for |y|<1.2, over the range 10
Precise determination of the mass of the Higgs boson and tests of compatibility of its couplings with the standard model predictions using proton collisions at 7 and 8[Formula: see text]. - The European physical journal. C, Particles and fields
Properties of the Higgs boson with mass near 125[Formula: see text] are measured in proton-proton collisions with the CMS experiment at the LHC. Comprehensive sets of production and decay measurements are combined. The decay channels include [Formula: see text], [Formula: see text], [Formula: see text], [Formula: see text], [Formula: see text], and [Formula: see text] pairs. The data samples were collected in 2011 and 2012 and correspond to integrated luminosities of up to 5.1[Formula: see text] at 7[Formula: see text] and up to 19.7[Formula: see text] at 8[Formula: see text]. From the high-resolution [Formula: see text] and [Formula: see text] channels, the mass of the Higgs boson is determined to be [Formula: see text]. For this mass value, the event yields obtained in the different analyses tagging specific decay channels and production mechanisms are consistent with those expected for the standard model Higgs boson. The combined best-fit signal relative to the standard model expectation is [Formula: see text] at the measured mass. The couplings of the Higgs boson are probed for deviations in magnitude from the standard model predictions in multiple ways, including searches for invisible and undetected decays. No significant deviations are found.

Map & Directions

2545 W Hammer Ln Stockton, CA 95209

Nearby Doctors

2545 West Hammer Lane
Stockton, CA 95209
209 577-7050
2545 W Hammer Ln
Stockton, CA 95209
209 577-7050
3108 W Hammer Ln Suite B
Stockton, CA 95209
209 576-6001
8807 Thornton Rd Suite A
Stockton, CA 95209
209 733-3221
1755 W Hammer Ln Ste 4
Stockton, CA 95209
209 527-7843
2505 W Hammer Ln
Stockton, CA 95209
209 577-7050
2545 W Hammer Ln
Stockton, CA 95209
209 577-7050
2505 W Hammer Ln
Stockton, CA 95209
209 577-7050
2505 W Hammer Ln
Stockton, CA 95209
209 577-7050
2505 W Hammer Ln
Stockton, CA 95209
209 577-7050